IL128561A0 - Stable non-hygroscopic crystalline form of N-(N-N-(4-(piperidin-4-YL)butanoyl)-N-ethylglycyl) compounds - Google Patents
Stable non-hygroscopic crystalline form of N-(N-N-(4-(piperidin-4-YL)butanoyl)-N-ethylglycyl) compoundsInfo
- Publication number
- IL128561A0 IL128561A0 IL12856197A IL12856197A IL128561A0 IL 128561 A0 IL128561 A0 IL 128561A0 IL 12856197 A IL12856197 A IL 12856197A IL 12856197 A IL12856197 A IL 12856197A IL 128561 A0 IL128561 A0 IL 128561A0
- Authority
- IL
- Israel
- Prior art keywords
- ethylglycyl
- butanoyl
- piperidin
- compounds
- crystalline form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2428496P | 1996-08-21 | 1996-08-21 | |
PCT/US1997/014756 WO1998007696A1 (en) | 1996-08-21 | 1997-08-21 | Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL128561A0 true IL128561A0 (en) | 2000-01-31 |
Family
ID=21819807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12856197A IL128561A0 (en) | 1996-08-21 | 1997-08-21 | Stable non-hygroscopic crystalline form of N-(N-N-(4-(piperidin-4-YL)butanoyl)-N-ethylglycyl) compounds |
Country Status (20)
Country | Link |
---|---|
US (2) | US6153588A (xx) |
EP (1) | EP0923553B1 (xx) |
JP (1) | JP4008499B2 (xx) |
KR (1) | KR20000068229A (xx) |
CN (2) | CN1231659A (xx) |
AP (1) | AP9901462A0 (xx) |
AT (1) | ATE390438T1 (xx) |
AU (1) | AU733591B2 (xx) |
BG (1) | BG63538B1 (xx) |
BR (1) | BR9711340A (xx) |
CA (1) | CA2263647C (xx) |
DE (1) | DE69738601T2 (xx) |
EA (1) | EA001362B1 (xx) |
IL (1) | IL128561A0 (xx) |
NO (1) | NO990721L (xx) |
OA (1) | OA10979A (xx) |
PL (1) | PL331772A1 (xx) |
SK (1) | SK21999A3 (xx) |
WO (1) | WO1998007696A1 (xx) |
ZA (1) | ZA977510B (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007696A1 (en) * | 1996-08-21 | 1998-02-26 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
WO1999019294A1 (en) * | 1997-05-14 | 1999-04-22 | Aventis Pharmaceuticals Products Inc. Legal/Patents | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
CN1278791A (zh) * | 1997-10-10 | 2001-01-03 | 阿温蒂斯药物制品公司 | 制造氮杂环烷基烷酰基假四肽的方法 |
WO2000040601A1 (en) * | 1998-12-30 | 2000-07-13 | Aventis Pharmaceuticals Products Inc. | Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide |
US20050238834A1 (en) * | 2004-04-21 | 2005-10-27 | Eastman Kodak Company | High modulus label with compliant carrier sheet |
US8021679B2 (en) | 2005-08-25 | 2011-09-20 | Medtronic Vascular, Inc | Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
US8241619B2 (en) | 2006-05-15 | 2012-08-14 | Medtronic Vascular, Inc. | Hindered amine nitric oxide donating polymers for coating medical devices |
US7811600B2 (en) * | 2007-03-08 | 2010-10-12 | Medtronic Vascular, Inc. | Nitric oxide donating medical devices and methods of making same |
US8273828B2 (en) * | 2007-07-24 | 2012-09-25 | Medtronic Vascular, Inc. | Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation |
US20090222088A1 (en) * | 2008-02-29 | 2009-09-03 | Medtronic Vascular, Inc. | Secondary Amine Containing Nitric Oxide Releasing Polymer Composition |
US20090232868A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Nitric Oxide Releasing Polymer Composition |
US20090232863A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers |
US8158187B2 (en) * | 2008-12-19 | 2012-04-17 | Medtronic Vascular, Inc. | Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
US8709465B2 (en) * | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
US9704557B2 (en) * | 2013-09-25 | 2017-07-11 | Qualcomm Incorporated | Method and apparatus for storing retention time profile information based on retention time and temperature |
CN108697770B (zh) | 2015-12-21 | 2023-08-01 | 得克萨斯技术大学联合体 | 用于溶液相gap肽合成的系统和方法 |
WO2019217116A1 (en) * | 2018-05-06 | 2019-11-14 | Gap Peptides Llc | Method for solution-phase peptide synthesis |
EP3917937A4 (en) | 2019-02-01 | 2022-11-23 | Sederma | SYNTHETIC STRATEGY FOR A SPLIT PROTECTION GROUP |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
US4992463A (en) * | 1988-07-20 | 1991-02-12 | Monsanto Company | Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation |
US4952562A (en) * | 1989-09-29 | 1990-08-28 | Rorer Pharmaceutical Corporation | Anti-thrombotic peptides and pseudopeptides |
US5332726A (en) * | 1989-09-29 | 1994-07-26 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic peptides and pseudopeptides |
US5064814A (en) * | 1990-04-05 | 1991-11-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
US5264420A (en) | 1990-09-27 | 1993-11-23 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5218138A (en) | 1992-09-02 | 1993-06-08 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Stereoselective reduction of 3-hydroxyket-1-ones to 1,3-syn-dihydroxylated compounds |
US5340798A (en) * | 1992-10-14 | 1994-08-23 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5607948A (en) * | 1993-06-30 | 1997-03-04 | Sumitomo Pharmaceuticals Co., Ltd. | Dipiperidine derivatives |
US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
EP0812205B1 (en) * | 1993-10-15 | 2001-03-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
WO1995011228A1 (fr) * | 1993-10-19 | 1995-04-27 | Sumitomo Pharmaceuticals Co., Ltd. | Derive d'acide 2,3-diaminopropionique |
WO1998007696A1 (en) * | 1996-08-21 | 1998-02-26 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
CN1278791A (zh) * | 1997-10-10 | 2001-01-03 | 阿温蒂斯药物制品公司 | 制造氮杂环烷基烷酰基假四肽的方法 |
-
1997
- 1997-08-21 WO PCT/US1997/014756 patent/WO1998007696A1/en not_active Application Discontinuation
- 1997-08-21 SK SK219-99A patent/SK21999A3/sk unknown
- 1997-08-21 AU AU41563/97A patent/AU733591B2/en not_active Ceased
- 1997-08-21 CN CN97198210A patent/CN1231659A/zh active Pending
- 1997-08-21 BR BR9711340A patent/BR9711340A/pt unknown
- 1997-08-21 ZA ZA9707510A patent/ZA977510B/xx unknown
- 1997-08-21 IL IL12856197A patent/IL128561A0/xx unknown
- 1997-08-21 EP EP97939488A patent/EP0923553B1/en not_active Expired - Lifetime
- 1997-08-21 AP APAP/P/1999/001462A patent/AP9901462A0/en unknown
- 1997-08-21 CA CA2263647A patent/CA2263647C/en not_active Expired - Fee Related
- 1997-08-21 DE DE69738601T patent/DE69738601T2/de not_active Expired - Lifetime
- 1997-08-21 PL PL97331772A patent/PL331772A1/xx unknown
- 1997-08-21 AT AT97939488T patent/ATE390438T1/de not_active IP Right Cessation
- 1997-08-21 EA EA199900217A patent/EA001362B1/ru not_active IP Right Cessation
- 1997-08-21 CN CNA021415722A patent/CN1491942A/zh active Pending
- 1997-08-21 JP JP51098398A patent/JP4008499B2/ja not_active Expired - Fee Related
- 1997-08-21 KR KR1019997001362A patent/KR20000068229A/ko not_active Application Discontinuation
-
1999
- 1999-02-16 NO NO990721A patent/NO990721L/no unknown
- 1999-02-18 US US09/251,030 patent/US6153588A/en not_active Expired - Fee Related
- 1999-02-19 OA OA9900037A patent/OA10979A/en unknown
- 1999-03-04 BG BG103225A patent/BG63538B1/bg unknown
-
2000
- 2000-08-15 US US09/639,634 patent/US6753409B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BG63538B1 (bg) | 2002-04-30 |
EP0923553B1 (en) | 2008-03-26 |
ZA977510B (en) | 1998-05-21 |
AP9901462A0 (en) | 1999-03-31 |
EP0923553A1 (en) | 1999-06-23 |
CN1491942A (zh) | 2004-04-28 |
WO1998007696A1 (en) | 1998-02-26 |
EA001362B1 (ru) | 2001-02-26 |
BG103225A (en) | 2000-01-31 |
OA10979A (en) | 2001-11-01 |
SK21999A3 (en) | 2000-02-14 |
NO990721D0 (no) | 1999-02-16 |
US6753409B1 (en) | 2004-06-22 |
DE69738601T2 (de) | 2009-04-30 |
EP0923553A4 (en) | 1999-12-08 |
BR9711340A (pt) | 1999-08-17 |
CA2263647A1 (en) | 1998-02-26 |
KR20000068229A (ko) | 2000-11-25 |
CA2263647C (en) | 2011-02-15 |
JP2000517305A (ja) | 2000-12-26 |
PL331772A1 (en) | 1999-08-02 |
EA199900217A1 (ru) | 1999-08-26 |
JP4008499B2 (ja) | 2007-11-14 |
ATE390438T1 (de) | 2008-04-15 |
NO990721L (no) | 1999-04-20 |
AU733591B2 (en) | 2001-05-17 |
CN1231659A (zh) | 1999-10-13 |
DE69738601D1 (de) | 2008-05-08 |
US6153588A (en) | 2000-11-28 |
AU4156397A (en) | 1998-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL128561A0 (en) | Stable non-hygroscopic crystalline form of N-(N-N-(4-(piperidin-4-YL)butanoyl)-N-ethylglycyl) compounds | |
AU7177296A (en) | Crystalline hydrochloride of (R)-(-)-2-N-(4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl)- aminomethyl-chroman | |
AP9901458A0 (en) | Crystalline form of 4-[5-methyl-3-phenylsoxanol-4-yl] benzenesulfonamide | |
HRP20010132B1 (en) | CRYSTALLINE FORMS OF EtO<SUB>2</SUB>C-CH<SUB>2</SUB>-(R)Cgl-Aze-Pab-OH | |
NO20004896D0 (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
ATE198889T1 (de) | Apolipoprotein-b syntheseinhibitoren | |
BR9607560A (pt) | Composições cométicas anidras contendo agentes dermatologicamente ativo | |
HUP9801844A3 (en) | New crystalline form of n-(4-trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid and process for the preparation thereof | |
DK0711774T3 (da) | Nye krystallinske cephem-syreadditionssalte og fremgangsmåder til deres fremstilling | |
ATE339438T1 (de) | Substanziell kristalline form von melagatran | |
AU5404800A (en) | Process for the preparation of optically active n-acyl derivatives of methyl n-(2,6-dimethylphenyl)-d-alaninate | |
HK1035535A1 (en) | Crystalline forms of osanetant | |
IL140385A0 (en) | Salts of paroxetine | |
HU9800146D0 (en) | Thalidomide compounds of piperidine-2,6-diones | |
PL344348A1 (en) | Process for preparing crystalline salts of amoxycillin | |
PL342931A1 (en) | Crystalline form of paroxetine | |
PL326501A1 (en) | N-(4-oxo-2(1htetrazoyl-5-yl)4h-1-benzopyran-8-yl)-4-(4-phenylobutoxy) benzamide salts | |
HUP9902682A3 (en) | Stable non-hygroscopic crystalline form of n-n-[n-(4-piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds, process for producing them and pharmaceutical compositions containing them | |
GB9929170D0 (en) | Crystalline pharmaceutically acceptable salts of an oxazolidinone derivative | |
AU2844800A (en) | Process for preparing a stable non-hygroscopic crystalline n-(n-(n- piperdin- 4-yl)butanoyl)- n.ethylglycyl)- (l)-aspartyl) -ss-cyclohexylalanine amide | |
SI1102747T1 (en) | Crystalline forms of osanetant | |
AU1398300A (en) | Amine salts of paroxetine | |
TW392803U (en) | Screw mounting machine of screw nail tape | |
TW414068U (en) | Pot frame capable of being used for stacked on both faces | |
SI1192134T1 (sl) | Postopki za pripravo (R)-alfa-(2,3-dimetoksifenil)-1-2-(4-fluorofenil) etil)-4-piperidinmetanola |